Navigation Links
Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call
Date:4/28/2008

SOUTH SAN FRANCISCO, Calif., April 28 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) will release its first quarter 2008 financial results on Tuesday, May 6, 2008, after the markets close. The announcement will be followed by a live webcast at 2:00 p.m. PT/5:00 p.m. ET, in which Exelixis management will discuss the first quarter financial results and give a general update on the company's financial position and business, including its development pipeline and corporate strategy. The webcast may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An archive of this webcast will be available until 8:59 p.m. PT/11:59 p.m. ET on June 6, 2008. Access numbers for this replay are 1-888-286-8010 (domestic) and 1-617-801-6888 (international); the replay passcode number is 37936947.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exelixis Announces April 30 Webcast of Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
2. Seven Abstracts Featuring Exelixis Compounds Accepted for Presentation at 2008 ASCO Annual Meeting
3. Option to Develop Exelixis Compound Exercised By Genentech
4. Exelixis Announces March 17 Webcast of Presentation at the Cowen and Company Annual Health Care Conference
5. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
6. Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results
7. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
8. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
9. Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
10. Exelixis Announces Senior Management Promotions
11. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015   Intrexon ... in synthetic biology, announced today the appointment of ... Vice President, Consumer Sector.  Mr. Jarry will lead ... in products and applications for consumer markets.  ... 30 years of experience in leading global life ...
(Date:6/2/2015)... /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO ) ("CCBC," ... leading provider of cord blood collection, laboratory testing, hematopoietic ... that the Special Committee of the Company,s board of directors ... China ) Limited as its independent financial advisor, ... United States legal counsel and Maples ...
(Date:6/2/2015)... 2015 Through rare discovery of new ... Corporation is enabling World Scientists to actually see, ... sample, displaying the full nature (position, shape, size, number) ... Jeff Porter, Co-Founder of the Yancy Corporation, says, "Our ... rare. They come once in a lifetime, if at ...
(Date:6/2/2015)... June 02, 2015 GenoCAD , ... to improve protein expression, announced the formation of its ... executives and entrepreneurs with a broad range of experience ... , The team includes: , Jimmy Roussel, Entrepreneur in ... has a background in technology and marketing. He has ...
Breaking Biology Technology:Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3
... -- BEIJING, Aug. 24 /PRNewswire-Asia/ -- ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... Kendle (Nasdaq: KNDL ), a ... the appointment of Jeffrey M. Zucker as Senior ... provide global leadership for the development and implementation ... retention and support the timely and efficient delivery ...
... Based on its recent analysis of the algae ... the 2010 Global Algae Biofuels Green Excellence in Technology ... possible solution to two crucial issues plaguing consumers – ... commercial production of algae biofuels needs a cost-effective technology ...
Cached Biology Technology:Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 2Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 3Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 4Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 5Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 6Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts 2Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 2Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 3Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 4
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... This week in the journal Science , Swedish and ... year old fossil fishes, revealed by unique fossils from a ... understand how neck muscles and abdominal muscles "abs" ... of rattling skeletons. Bones and teeth fossilize far more easily ...
... 12 June 2013: Data presented at EULAR 2013, the ... that novel antibody biomarkers could significantly improve diagnosis in ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; as ... were present in both early and seronegative disease, ...
... test previously developed to measure a toxin found in ... toxin in people suffering from spinal cord injuries and ... , The toxin, called acrolein, is produced in the ... of biochemical events thought to worsen the injury,s severity. ...
Cached Biology News:Testing method promising for spinal cord injuries, multiple sclerosis 2Testing method promising for spinal cord injuries, multiple sclerosis 3
... calcium binding proteins such as calmodulin and troponin ... and beta chain whereas S100B is composed of ... expressed in the antigen presenting cells such as ... cells in the paracortex of lymph nodes. ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Purified anti-eIF-4E...
Biology Products: